BaseSpace
Correlation
Engine-Public
Sign In
Register
Home
My Data
Bookmarks
Collaborations
Inbox
Import Your Data
QuickView
FAQ
What is QuickView?
What can my QuickView results tell me?
What are the sources for the General Info tab in QuickView?
More QuickView FAQs
Back to top
QuickView
Curated
Studies
Body
Atlas
Disease
Atlas
Pharmaco
Atlas
Knockdown
Atlas
Genetic
Markers
Pathway
Enrichment
Literature
Clinical
Trials
0
Meta-
Analysis
QuickView
Search sequence regions
(e.g.
rs6983267
,
PPARA
,
Fatty acid metabolic process
,
Leukemia
,
Hypothalamus
,
Biofuel
)
Organisms
Chromosomes
Start
Stop
Homo Sapiens
Mus Musculus
Rattus Norvegicus
C. Elegans
D. Melanogaster
Saccharomyces Cerevisiae
QuickView
Go back to main search
Bookmark
Forward
QuickView
for
viremia
(phenotype)
Summary
General Info
Genetic Markers
Most Correlated Genes
Most Correlated SNPs
NUP210L
KIF26A
LOC283683
BEX1
LINC01875
No SNPs found
Explore Genetic Markers Results
Pathway Enrichment
Most Correlated Biogroups
TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_8D_UP
HECKER_IFNB1_TARGETS
GSE13485_DAY3_VS_DAY7_YF17D_VACCINE_PBMC_DN
GSE21927_SPLEEN_C57BL6_VS_4T1_TUMOR_BALBC_MONOCYTES_DN
GSE42724_NAIVE_BCELL_VS_PLASMABLAST_UP
Explore Pathway Enrichment Results
Curated Studies
Most Correlated Studies
IFN and ribavirin therapy effect on liver and liver infiltrating lymphocytes in HCV viremia patients
Whole blood mRNA expression profiling in neonatal sepsis
Explore Curated Studies Results
Literature
Most Relevant Literature
Non-suppressible viraemia during HIV-1 therapy: a challenge for clinicians.
Periodontal inflammation as a potential driver of HIV low level viremia.
Generation of Recombinant Snakehead Rhabdovirus (SHRV) Expressing Artificial MicroRNA Targeting Spri…
Dynamics of Low-Level Viremia and Immune Activation after Switching to a Darunavir-Based Regimen.
Nonsuppressible viremia during HIV-1 therapy meets molecular virology.
Explore Literature Results
Clinical Trials
Most Relevant Clinical Trials
Evaluation of HCV Viremia Testing Approaches Among PWID in Georgia
BK Virus Infection (Viremia) Natural History in Renal Transplant Recipients
IVIg to Treat BK Viremia in Kidney Transplant Recipients
Predictors of Time to Viremia With an Analytic Treatment Interruption
Expanded Access Protocol of ATA230 (Third-Party Donor-Derived CMV-CTLs) for the Treatment of CMV Vir…
Explore Clinical Trials Results
search
→
result
search
→
result
See more about this page
See complete FAQ